BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35156575)

  • 1. Network-based Drug Repurposing: A Critical Review.
    Selvaraj N; Swaroop AK; Nidamanuri BSS; Kumar RR; Natarajan J; Selvaraj J
    Curr Drug Res Rev; 2022; 14(2):116-131. PubMed ID: 35156575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of network-based approaches to drug repositioning.
    Lotfi Shahreza M; Ghadiri N; Mousavi SR; Varshosaz J; Green JR
    Brief Bioinform; 2018 Sep; 19(5):878-892. PubMed ID: 28334136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNBDR: A Module Network Based Method for Drug Repositioning.
    Chen HG; Zhou XH
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing old molecules for new indications: Defining pillars of success from lessons in the past.
    Mittal N; Mittal R
    Eur J Pharmacol; 2021 Dec; 912():174569. PubMed ID: 34653378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based drug repurposing for schizophrenia.
    Truong TTT; Liu ZSJ; Panizzutti B; Kim JH; Dean OM; Berk M; Walder K
    Neuropsychopharmacology; 2024 May; 49(6):983-992. PubMed ID: 38321095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing based on drug-drug interaction.
    Zhou B; Wang R; Wu P; Kong DX
    Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network controllability solutions for computational drug repurposing using genetic algorithms.
    Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
    Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.
    Su Y; Wu J; Li X; Li J; Zhao X; Pan B; Huang J; Kong Q; Han J
    Comput Biol Med; 2023 Jun; 159():106969. PubMed ID: 37105108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network inference with ensembles of bi-clustering trees.
    Pliakos K; Vens C
    BMC Bioinformatics; 2019 Oct; 20(1):525. PubMed ID: 31660848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.
    Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
    Biomed Res Int; 2021; 2021():1280237. PubMed ID: 34692825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of genetic variants and gene network for drug repurposing in colorectal cancer.
    Irham LM; Wong HS; Chou WH; Adikusuma W; Mugiyanto E; Huang WC; Chang WC
    Pharmacol Res; 2020 Nov; 161():105203. PubMed ID: 32950641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of the methodology in drug repurposing using human genomic data: a systematic review.
    Wang L; Lu Y; Li D; Zhou Y; Yu L; Mesa Eguiagaray I; Campbell H; Li X; Theodoratou E
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38279645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico methods for drug repurposing and pharmacology.
    Hodos RA; Kidd BA; Shameer K; Readhead BP; Dudley JT
    Wiley Interdiscip Rev Syst Biol Med; 2016 May; 8(3):186-210. PubMed ID: 27080087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.